Did anyone get full genomic profiling on the tumour, not just the basic panel? My uncle is stage 4 and I keep...

November 18, 2026Written by Navis AI

1) Did anyone get full genomic profiling, and what does it involve?

Yes, many people do, and your instinct is well-founded. I'm sorry your family is dealing with this.

Where the webinars come in. Cancer Patient Lab's community has several sessions on exactly this, and it's a good place to hear patients describe their own experiences.

  • "The BostonGene Tumor Portrait Report and How to Access It" (Michael Hensley and Michelle Lanman, Webinar #72) explains how whole exome DNA sequencing and whole transcriptome RNA sequencing differ from a basic panel, and how to request the testing.
  • "Integrating Diverse Test Results for Cancer Patient Guidance" (Joe Lennerz, MD, PhD, MSc, Webinar #142) covers how comprehensive results are interpreted in the context of a patient's treatment timeline, plus cost and insurance.
  • "Advanced Cancer Testing: Genomic & Molecular Profiling for Patients" (Brad Power, Webinar #83) is a patient's account of using several kinds of tests together.

I can't see a direct link in the material I have, so please check the Cancer Patient Lab website (cancerpatientlab.org) for the webinar library.

What "full" profiling means. A basic panel typically checks a small set of genes. Comprehensive genomic profiling (CGP) examines hundreds of genes and can also detect fusions, copy number changes, and biomarkers like microsatellite instability (MSI) and tumor mutational burden (TMB). Examples include FoundationOne CDx (324 genes), MSK-IMPACT (468 genes), and Tempus xT CDx (648 genes). Some tests also add RNA sequencing, which can catch fusions that DNA-only tests may miss. A speaker in Webinar #72 notes that DNA sequencing is now common while RNA sequencing is less so.

Why it matters in stage 4 disease. The NCCN Guidelines for several cancers recommend molecular testing in the advanced setting:

  • Non-small cell lung cancer: NCCN calls for "broad molecular profiling" covering EGFR, ALK, KRAS, ROS1, BRAF, NTRK1/2/3, MET, RET, ERBB2 (HER2) and NRG1, plus PD-L1.
  • Prostate cancer: NCCN recommends tumor molecular and biomarker analysis for metastatic disease, including multigene testing for DNA repair genes (BRCA1/2, ATM and others), MSI/mismatch repair status, and TMB.
  • Ovarian cancer: NCCN recommends germline and somatic testing, with tumor molecular analysis again at recurrence.

I don't know your uncle's cancer type, but this pattern is common across advanced cancers.

Good to know:

  • Tissue and blood (liquid biopsy) tests can complement each other. NCCN's lung guidelines note that both have false-negative rates, and blood tests can sometimes pick up changes unrelated to the tumor.
  • Results can change over time, so some patients are retested at progression.
  • Tests need enough tumor tissue. One speaker in Webinar #83 mentions a minimum of about 30% tumor purity for their test, so older or small biopsies can be a limit.
  • Insurance coverage varies. Medicare covers some tests, and some labs offer financial assistance.

Tell us what’s going on with your cancer. 2 free answers, then a free account.

2) Is it worth raising with his team? Is it "adding stress for nothing"?

You're not adding stress for nothing. In stage 4 disease this is a standard, reasonable question, and oncologists hear it often. There's a good chance testing has already been done and just hasn't been discussed with the family. Asking is also a different thing from pushing. A neutral, curious question is usually well received.

Questions you could ask his team:

  1. "Has my uncle's tumor had molecular or genomic testing? Was it a limited panel or comprehensive profiling?"
  2. "Which biomarkers were checked, and could we see the results?"
  3. "Would broader testing, including RNA sequencing or a liquid biopsy, add anything for his type of cancer?"
  4. "Is there enough tissue from his biopsy, or would a new sample be needed?"
  5. "Could the results open up targeted therapy, immunotherapy, or clinical trials, or would they not change the plan?"
  6. "Who should we ask about insurance coverage or financial assistance?"

Some perspective: comprehensive testing doesn't find something actionable for everyone. In Webinar #142, the speaker says plainly that it isn't for everyone and has to be applied meaningfully. Sometimes the answer is "the standard plan is still the best one," and that's useful information too. Because this is your uncle's decision, it's best to raise this with him and let him lead.

Your uncle's oncologist will determine the most appropriate approach for his case, based on his cancer type, prior treatments, overall health, and goals.

Summary of coverage: Topic 1 (genomic profiling) has strong support from NCCN guidelines, the OpenOnco test directory, and the Cancer Patient Lab webinars. Topic 2 (whether to ask) rests on the same material plus the shared decision-making principles in the NCCN Guidelines for Patients. Your uncle's specific cancer type would let me point to more targeted guidelines.

This information is for educational purposes only. Always consult your healthcare team for personalized medical advice and decisions.

Your next question, already answered

Tap to keep going. 2 free answers, then a free account.

Ask Navis about your case

That answer is general. Ask about your specific situation. Answered right here.

For informational purposes only

This answer was generated by AI grounded in NCCN guidelines and published medical literature. It is not medical advice. Always consult your oncologist or care team before making treatment decisions.

Sources & medical oversight

  • Built by OpenCancer’s team of physician-scientists and cancer survivors.
  • Last updated November 18, 2026. Informational only — not a substitute for your oncology team.

Question asked:

Did anyone get full genomic profiling on the tumour, not just the basic panel? My uncle is stage 4 and I keep reading that the molecular profile can change which treatment makes sense, but his team hasn't raised it. Wondering if it's worth pushing for or if I'm just adding stress for nothing.

Facing this with someone you love?

Keep the whole picture in one private place: records, a plain-language summary of where things stand, questions, and the people helping. Navis keeps it up to date so no one has to re-explain the story. Free, and only the people you invite can ever see it.

Start a care circle →

More questions about General